Literature DB >> 6142013

The endocrinological evaluation of bilateral and unilateral oophorectomy in premenopausal women.

M S Beksaç, H A Kişnişci, A N Cakar, M Beksaç.   

Abstract

The sequence of changes in serum follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), estradiol (E2), testosterone (T), and progesterone (P) levels immediately following unilateral and bilateral oophorectomy with hysterectomy and hysterectomy alone has been measured in 65 premenopausal women by radioimmunoassay (RIA). In addition, relationship of vasomotor symptoms and serum hormone levels were studied and no correlation was found. We show mathematically the change of the relationship of the pituitary and gonadal hormones after castration. We believe that castration causes change in the activity of the hypothalamo-pituitary and gonadal axis. In view of our results, we recommend leaving at least one ovary to prevent postcastration symptoms and to maintain a good physiological condition.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6142013

Source DB:  PubMed          Journal:  Int J Fertil        ISSN: 0020-725X


  3 in total

1.  Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.

Authors:  R Pacifici; C Brown; E Puscheck; E Friedrich; E Slatopolsky; D Maggio; R McCracken; L V Avioli
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

2.  Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.

Authors:  A R Dixon; J F Robertson; L Jackson; R I Nicholson; K J Walker; R W Blamey
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

3.  Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical Oncology.

Authors:  R Buzzoni; L Biganzoli; E Bajetta; L Celio; A Fornasiero; L Mariani; N Zilembo; M Di Bartolomeo; A Di Leo; G Arcangeli
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.